Learn more about whether Alvotech or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which compare ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

That month, Canadian fund Brookfield dropped its plan to take over Grifols due to a disagreement over the pharmaceutical company's value. Spain's stock market regulator CNMV has earlier opened ...

In a presentation to investors in London, Grifols said it expects positive free cash flow - excluding the impact of costs and expenses from merger and acquisitions - to rise to 1.2 billion euros ...

Mason Capital complains about Grifols' transparency to Spanish regulator U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV ...

Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

It's time for an update on the Medical company Grifols, S.A. (NASDAQ:GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where ...

In this article, we are going to take a look at where Grifols, S.A. (NASDAQ ... Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency ...

Spanish drugmaker Grifols said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in the coming years as it aims to leave behind a tumultuous 2024 when it lost ...

In November, an investigating magistrate at Spain's High Court opened a probe into Gotham's actions over the possible violation of market and consumer protection laws. That month, Canadian fund ...

Shares in Grifols soared 13 per cent on the day following its new outlook presentation, extending early gains after the release of a strong set of 2024 results on Wednesday, while Spain’s blue ...